09/15/2026
We’re proud to share that the Texas Retina Dallas research team has been recognized as the highest-enrolling site globally for Part I of the DFI18231 study evaluating SAR446597 for geographic atrophy secondary to age-related macular degeneration (AMD).
Part II of the study opened in August, and both Texas Retina’s Dallas and Fort Worth research teams are participating.
Learn more: https://www.texasretina.com/2026/09/15/texas-retina-dallas-research-team-recognized-for-highest-site-enrollment-globally-in-geographic-atrophy-clinical-trial